ID
13434
Description
Antibiotic-associated diarrhoea (AAD) is a frequent condition in hospitalised patients receiving antibiotic treatment. The same is true for Clostridium difficile-associated diarrhoea (CDAD) with even more grave consequences of increased morbidity and mortality. The development and evaluation of preventive strategies is one key public health challenge. In the absence of clinically evaluated alternatives, probiotics have been suggested to be beneficial for the prevention of AAD and CDAD. However, data have so far been inconclusive and recently published meta-analyses strongly recommended large state-of-the-art clinical trials on probiotic substances for the prevention of AAD and CDAD. Since the efficacy, side-effects and modes of action of different probiotic bacteria and yeast are strain specific, benefits and risks cannot be generalised. The non-pathogenic yeast Saccharomyces cerevisiae var. boulardii (Sac. boulardii) is considered the most promising probiotic substance for the prevention of AAD and CDAD. We carry out a randomised, placebo controlled, double blind multicentre clinical trial to evaluate Sac. boulardii for the indication of prevention of AAD and CDAD in 1520 adult, hospitalised patients.
Mots-clés
Versions (2)
- 09/02/2016 09/02/2016 -
- 11/02/2016 11/02/2016 -
Téléchargé le
11 de fevereiro de 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
SacBo PZ: Case Report Form Hospitalization Documentation Diarrhea - AAD - CDAD DRKS00000084 NCT01143272
SacBo PZ: Case Report Form Hospitalization Documentation Diarrhea - AAD - CDAD NCT01143272
Description
Clinical diagnosis
Description
Bloody stool
Type de données
integer
Alias
- UMLS CUI [1]
- C0018932
Description
Abdominal pain/cramp
Type de données
integer
Alias
- UMLS CUI [1]
- C0000737
- UMLS CUI [2]
- C0000729
Description
Dehydration
Type de données
integer
Alias
- UMLS CUI [1]
- C0011175
Description
Fever
Type de données
integer
Alias
- UMLS CUI [1]
- C0015967
Description
Medication
Type de données
boolean
Alias
- UMLS CUI [1]
- C0013227
Description
Conservative or surgical therapy for AAD/CDAD
Description
Further therapy for AAD/CDAD. (Antibiotics should only be documented as "medication subject to documentation")
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0578159
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [2,1]
- C0235952
- UMLS CUI [2,2]
- C0087111
Description
If there was further treatment necessary please specify: (1 treatment per line)
Type de données
text
Alias
- UMLS CUI [1,1]
- C0578159
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [2,1]
- C0235952
- UMLS CUI [2,2]
- C0087111
Description
Further episode of diarrhea/AAD/CDAD
Description
Further episode of diarrhea/AAD/CDAD or further stool sample acquired? According to the study protocol there must be at least 5 days without any symptoms between 2 episodes of diarrhea.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0011991
- UMLS CUI [2]
- C0578159
- UMLS CUI [3]
- C0235952
Similar models
SacBo PZ: Case Report Form Hospitalization Documentation Diarrhea - AAD - CDAD NCT01143272
C0578159 (UMLS CUI [2])
C0235952 (UMLS CUI [3])
C0011008 (UMLS CUI [1,2])
C0430414 (UMLS CUI [2])
C0014245 (UMLS CUI [2])
C0026376 (UMLS CUI [2])
C0000729 (UMLS CUI [2])
C0087111 (UMLS CUI [1,2])
C0235952 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0087111 (UMLS CUI [1,2])
C0235952 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0578159 (UMLS CUI [2])
C0235952 (UMLS CUI [3])